Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,007 | -1,493 | N/A | -3,086 | -1,313 |
| Depreciation Amortization | 310 | 154 | N/A | 366 | 201 |
| Accounts receivable | 109 | 164 | N/A | -11 | 14 |
| Other Working Capital | -24 | 236 | N/A | -3,515 | -3,517 |
| Other Operating Activity | 16 | -89 | 0 | 251 | 113 |
| Operating Cash Flow | $-2,596 | $-1,029 | $N/A | $-5,994 | $-4,502 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,989 | N/A | N/A | 690 | 690 |
| PPE Investments | 4 | 2 | N/A | 52 | 40 |
| Other Investing Activity | -130 | -101 | 0 | -254 | -10 |
| Investing Cash Flow | $-2,115 | $-99 | $N/A | $488 | $720 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -17 | -11 | N/A | -71 | -36 |
| Common Stock Issued | 4,628 | 338 | N/A | 4,864 | 4,864 |
| Financing Cash Flow | $4,612 | $327 | $N/A | $4,793 | $4,829 |
| Beginning Cash Position | 1,813 | 1,813 | N/A | 3,287 | 3,287 |
| End Cash Position | 1,429 | 755 | N/A | 2,206 | 4,005 |
| Net Cash Flow | $-384 | $-1,058 | $N/A | $-1,081 | $718 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,596 | -1,029 | N/A | -5,994 | -4,502 |
| Free Cash Flow | -2,596 | -1,029 | 0 | -5,994 | -4,502 |